These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Elevated Adenosine Deaminase Levels in the Cerebrospinal Fluid in Immune Checkpoint Inhibitor-induced Autoimmune Encephalitis. Fujiwara S; Mimura N; Yoshimura H; Fujimoto D; Ito M; Mori R; Ito J; Tomii K; Kawamoto M; Kohara N Intern Med; 2019 Oct; 58(19):2871-2874. PubMed ID: 31243206 [TBL] [Abstract][Full Text] [Related]
4. Association of Autoimmune Encephalitis With Combined Immune Checkpoint Inhibitor Treatment for Metastatic Cancer. Williams TJ; Benavides DR; Patrice KA; Dalmau JO; de Ávila AL; Le DT; Lipson EJ; Probasco JC; Mowry EM JAMA Neurol; 2016 Aug; 73(8):928-33. PubMed ID: 27271951 [TBL] [Abstract][Full Text] [Related]
5. Immune checkpoint inhibitor-associated CNS autoimmune disorder (ICICAD) following nivolumab treatment: A new entity of drug-induced autoimmune encephalitis? Strik H; Keber U; Hammoud WA; Riera-Knorrenschild J; Carl B; Dodel R; Pagenstecher A; Neubauer A Eur J Cancer; 2017 Dec; 87():205-208. PubMed ID: 29050806 [No Abstract] [Full Text] [Related]
6. A Case Report of Steroid Responsive Nivolumab-Induced Encephalitis. Richard K; Weslow J; Porcella SL; Nanjappa S Cancer Control; 2017; 24(5):1073274817729069. PubMed ID: 28975824 [TBL] [Abstract][Full Text] [Related]
8. Encephalitis related to immunotherapy for lung cancer: Analysis of a multicenter cohort. Sanchis-Borja M; Ricordel C; Chiappa AM; Hureaux J; Odier L; Jeannin G; Descourt R; Gervais R; Monnet I; Auliac JB; Chouaïd C Lung Cancer; 2020 May; 143():36-39. PubMed ID: 32200139 [TBL] [Abstract][Full Text] [Related]
9. Recurrent autoimmune encephalitis related to immune checkpoint inhibitors. Ser MH; Samanci NŞ; Ak N; Aydiner A; Özkara Ç Epileptic Disord; 2022 Jun; 24(3):609-613. PubMed ID: 35770759 [No Abstract] [Full Text] [Related]
10. A case of de novo palmoplantar psoriasis with psoriatic arthritis and autoimmune hypothyroidism after receiving nivolumab therapy. Elosua-González M; Pampín-Franco A; Mazzucchelli-Esteban R; Mielgo-Rubio X; Rodriguez-Vásquez X; García-Zamora E; López-Estebaranz JL Dermatol Online J; 2017 Aug; 23(8):. PubMed ID: 29469753 [TBL] [Abstract][Full Text] [Related]
11. "Limbic encephalitis with acute onset and Hu antibodies treated with rituximab: Paraneoplastic or non-paraneoplastic disorder?". Lapucci C; Benedetti L; Tavarelli C; Serrati C; Godani M; Schenone A; Franciotta D Clin Neurol Neurosurg; 2019 Sep; 184():105424. PubMed ID: 31330415 [TBL] [Abstract][Full Text] [Related]
12. Atezolizumab-associated encephalitis in metastatic lung adenocarcinoma: a case report. Yamaguchi Y; Nagasawa H; Katagiri Y; Wada M J Med Case Rep; 2020 Jul; 14(1):88. PubMed ID: 32620173 [TBL] [Abstract][Full Text] [Related]
13. Coexistence of Anti-SOX1 and Anti-GABA Qin W; Wang X; Yang J; Hu W Clin Interv Aging; 2020; 15():171-175. PubMed ID: 32103919 [TBL] [Abstract][Full Text] [Related]
14. Immune checkpoint inhibitor use in antisynthetase syndrome. Mackintosh D; Islam MF; Ng J; Basham J Asia Pac J Clin Oncol; 2019 Aug; 15(4):266-269. PubMed ID: 30815986 [TBL] [Abstract][Full Text] [Related]
15. Immune checkpoint inhibitor efficacy and safety in older non-small cell lung cancer patients. Kubo T; Watanabe H; Ninomiya K; Kudo K; Minami D; Murakami E; Ochi N; Ninomiya T; Harada D; Yasugi M; Ichihara E; Ohashi K; Rai K; Fujiwara K; Hotta K; Tabata M; Maeda Y; Kiura K Jpn J Clin Oncol; 2020 Dec; 50(12):1447-1453. PubMed ID: 32869100 [TBL] [Abstract][Full Text] [Related]
16. Glial fibrillary acidic protein (GFAP) associated autoimmune meningoencephalitis in a patient receiving nivolumab. Kapadia RK; Ney DE; Hannan M; Farley M; Pastula DM; Piquet AL J Neuroimmunol; 2020 Jul; 344():577259. PubMed ID: 32416558 [TBL] [Abstract][Full Text] [Related]
17. [Research progress of immune checkpoint inhibitors in clinical diagnosis and treatment of non-small cell lung cancer]. Huang Y; Xu K; Wang W; Cui F; Zeng Y; Hao ZX; Cai WP; He JX; Liu J Zhonghua Zhong Liu Za Zhi; 2020 Sep; 42(9):713-717. PubMed ID: 32988151 [TBL] [Abstract][Full Text] [Related]
18. PD-1 checkpoint blockade alone or combined PD-1 and CTLA-4 blockade as immunotherapy for lung cancer? Tanvetyanon T; Gray JE; Antonia SJ Expert Opin Biol Ther; 2017 Mar; 17(3):305-312. PubMed ID: 28064556 [TBL] [Abstract][Full Text] [Related]
19. [Immuno-checkpoint inhibitor resistance and strategy in lung cancer]. Jiang WR; Fang LP; Chang N; Zhang J Zhonghua Jie He He Hu Xi Za Zhi; 2020 Jul; 43(7):603-606. PubMed ID: 32629564 [TBL] [Abstract][Full Text] [Related]
20. Using Immune Checkpoint Inhibitors in Lung Cancer. Marrone KA; Brahmer JR Oncology (Williston Park); 2016 Aug; 30(8):713-21. PubMed ID: 27528240 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]